Zimeldine induced neuropathies.
Zimeldine is recently-introduced antidepressant drug. It has a novel pyridylallylamine structure and acts by selective inhibition of 5-hydroxytryptamine re-uptake at central nerve synapses. This communication reports 2 patients who developed neuropathies within 1 week of starting treatment with this drug. This has hitherto not been described.
D000328:Adult; D005260:Female; D006801:Humans; D008875:Middle Aged; D010523:Peripheral Nervous System Diseases / Q000139:chemically induced*; D012701:Serotonin / Q000502:physiology; D015031:Zimeldine / Q000009:adverse effects*
D012701:Serotonin; D015031:Zimeldine